Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02188147 · ClinicalTrials.gov registry record · NA

Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study

A NA study, sponsored by Zoll Medical Corporation.

Completed
Registry status
NA
Development phase
39
Enrollment target

NCT02188147 is a NA study that has completed, run by Zoll Medical Corporation. The registered enrollment target is 39 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02188147, a NA study, has completed, sponsored by Zoll Medical Corporation.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target

Study Summary

The purpose of this study is to conduct an observational investigation of a novel care path used to manage emergency department (ED) presenting syncope patients on an outpatient basis.

Interventions

  • DEVICE Short Term Wearable Defibrillator

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2014-08
Est. Completion 2020-04-15
Phase NA

Sponsor

Zoll Medical Corporation

24 total trials

What the Registry Record Tells You About NCT02188147

The ClinicalTrials.gov registry entry for NCT02188147 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zoll Medical Corporation, which has 24 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Short Term Wearable Defibrillator is the first listed.

NCT02188147 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02188147 about?

NCT02188147 is a clinical study titled "Ambulatory Post-Syncope Arrhythmia Protection Feasibility Study". The purpose of this study is to conduct an observational investigation of a novel care path used to manage emergency department (ED) presenting syncope patients on an outpatient basis.

What is the current status of trial NCT02188147?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2014-08. Estimated completion is 2020-04-15.

What interventions are being tested in trial NCT02188147?

The interventions under investigation include: Short Term Wearable Defibrillator (DEVICE).

Who is sponsoring clinical trial NCT02188147?

This trial is sponsored by Zoll Medical Corporation, which has 24 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.